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INTRODUCTION
Even the most modern intravenous radiographic contrast 
media (ICM) can induce allergic reactions, including 
urticaria, hypotension and respiratory failure. Acute drug-
induced immune thrombocytopenia is a very rare event 
following ICM. Only a few cases have been reported so far 
(1-6). Thrombocytopenia occurs usually within a few hours, 
without bleeding or evidence of disseminated intravascular 
coagulation and microangiopathic thrombocytopenia. 
An immunoallergic mechanism is postulated to be 
in the background of such an idiosyncratic reaction. 
Thrombocytopenia may develop after the very first 
administration of ICM. 
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Case Report
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Here we report on a case of a 72-year-old male patient 
with a self-limiting severe acute drug-induced immune 
thrombocytopenia following exposure to non-ionic low 
osmolarity intravenous radiographic contrast medium. No 
such low platelet count has ever been reported before.
CASE REPORT
A 72-year-old extremely obese (Body Mass Index: 42.3 
kg/m2) man was admitted to our radiology department 
for an abdominal CT scan. The patient had a history of 
a solitary papillary carcinoma (TCC, T1G3) in the urinary 
bladder which had been treated by transurethral resection 
one year earlier. No recurrence was detected by regular 
cystoscopy and cytology controls. A contrast enhanced 
CT scan was performed to clarify the cause of pyelectasia 
and mixed echodensity in the parenchyma in both kidneys 
detected by US at the latest urological check up four weeks 
earlier.
The patient had metabolic syndrome with obesity, a 
history of hypertension for 10 years, diabetes mellitus type 
II. for 6 months without the necessity of medical treatment. 
A small benign colonic polyp was removed endoscopically 
four years earlier. His daily medication consisted of 
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tamsulosin 0.4 mg, carvedilol 12.5 mg, enalapril 20 mg, 
enalapril-maleate 20 mg, hydroclorothiazide 12.5 mg 
and doxazosine 4 mg. He was on a sugar-free and a low 
carbohydrate diet.
An abdominal, single dose, non-ionic low osmolarity 
contrast agent (120 mL, Optiray 350©, Covidien, 25 
February, 2009, 1st day, 4 pm) (Fig. 1) enhanced CT scan 
detected a left renal cyst and an enlarged prostate with 
an inhomogeneous structure. No sign of malignancy was 
detected. No immediate allergic reaction was observed.
Forty minutes after the examination, he exhibited 
sudden respiratory distress, creeps started, and elevated 
blood pressure (190/100 mm Hg). No chest pain, swelter, 
urticaria, itches, rash, sore throat or cough were noticed. 
The patient vomited once, and enuresis and encopresis 
developed. No black-outs or seizures were noticed. Oxygen 
therapy and non-invasive ventilation was applied. The 
patient was then admitted to the intensive care unit.
Myocardial infarction and pulmonary embolism were 
excluded. A transient fever of 38.0°C was seen. Blood 
pressure returned to normal and the presenting symptoms 
spontaneously ceased. After some hours, petechiae 
appeared on the extremities. Severe thrombocytopenia 
with a lowest value of 2 x 109 Lit-1 was the only laboratory 
abnormality. The patient received methylprednisolone (125 
mg) intravenously and a platelet suspension (8 units). 
The platelet count gradually returned to the normal range 
by day 5 and remained normal during 20 months follow 
up (Fig. 1). A fecal occult blood test was positive, but no 
macroscopic bleeding was observed. Moderate and transient 
elevations of white blood cell (WBC) counts (15.4 G/Lit) 
and C-reactive protein (CRP) levels (up to 43 IU) were 
observed on day 3. These parameters returned to the normal 
range by day 6. No eosinophilia was observed. There was 
no significant change in hemoglobin, hematocrit, mean 
corpuscular volume (MCV), mean cell hemoglobin (MCH), 
content or mean cell hemoglobin concentration (MCHC) 
values. The transient and minor increase in mean platelet 
volume (MPV) is considered as the natural consequence of 
the compensatory accelerated platelet production (Table 
1). Hematological or immunological diseases and actual 
malignancies were excluded.
The chest X-ray showed a light transparency decrease on 
the right side at day 1, which was not present at day 3. 
On day 5, a chest CT was performed which found a small 
fibrotic linear shadow and three small nodules (2-3 mm) 
on the right side. No sign of pneumonia, or indirect signs 
of emboli or malignancy were detected. The patient was 
discharged on the 7th day. 
Follow Up
Ten months later, a cranial CT examination was performed 
using no ICM due to neurological symptoms of transient 
sensory disturbances of the right hand. Leucoarainosis 
around the ventricles and two small (6-7 mm) hypodensity 
chronic ischemic lesions were detected. No signs of bleeding 
or malignancy were detected.
Platelet counts were in the normal range during the 14 
Fig. 1. Platelet (PLT) level before and after development of acute severe thrombocytopenia. It should be noted that time scale is non-
proportional; it refers to Dates studied. 
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month follow-up period. No recurrence of the colonic polyp 
or urinary bladder malignancy and no hematological disease 
were detected. The patient successfully reduced his body 
weight using a strong diet. Blood sugar, blood pressure and 
all laboratory findings moved into the normal range. The 
patient was without any complaint.
In Vitro Test with ICM on the Blood of the Patient
To investigate the incidental direct effect of the ICM 
(Optiray 350©, Covidien) on the patient’s platelets we 
performed an in vitro test. ICM solution was added to both 
EDTA and citrate anticoagulated blood samples of the 
patient in concentrations corresponding to the estimated 
in vivo concentration at the time of contrast enhanced CT. 
Platelet counts were measured every 10 minutes throughout 
the 3 hours and then every 20 minutes up to 5 hours. There 
was no significant change in the platelet counts during the 
observed time period. The values varied between 246 and 
266 G/L.
The experiments were repeated by adding surplus 
plasma of the patient to the tubes to exclude the lack of a 
sufficient amount of complement and immunoglobulins in 
the system. No change in the platelet count was observed 
following the administration of ICM in this setting.
These tests were performed six months after recovery.
DISCUSSION
The history of development of intravenous contrast 
materials clearly shows a significant reduction of adverse 
events. However, even the most modern non-ionic 
low molecular contrast materials may induce adverse 
events including acute severe thrombocytopenia as a 
rare complication in some patients who usually have a 
genetically determined idiosyncrasy or most frequently 
an immunologically mediated hypersensitivity. The 
curiosity of our present case was the acute very severe 
thrombocytopenia with an extremely low platelet count and 
rapid recovery.
In a recent retrospective review from the Mayo clinic, 
adverse events were reported in 0.11% of more than four 
hundred thousand cases with low-osmolar iodinated and 
gadolinium contrast agent investigations; 0.15% for low 
osmolar iodinated and 0.04% for gadolinium contrast 
doses (7). The most common adverse effects were hives 
and nausea. Only 16 cases of adverse effects necessitated 
transfer for further observation or treatment in other unit 
than the radiology department. Only one death in the 
study period occurred after administration of low-osmolar 
iodinated contrast material. The patient had no symptoms 
during the contrast administration or imaging but died 
Table 1. Laboratory Test Characteristics before and after Development of Acute Severe Thrombocytopenia
1 Months 
Before
1st Day
2nd Day  
6 am
2nd Day  
7 pm
3rd Day  
7 am
4th Day 5th Day 6th Day 7th Day
Plt (G/L) 257 4 2 37 52 82 99 157 205
MPV (fL) 8.5 - - 9.1 - 11.7 10.4 10.9 9.9
Hgb (G/L) 116 - 104 105 105 110 108 110 109
Ht (L/L) 0.35 - 0.34 0.34 0.34 0.36 0.35 0.36 0.35
MCV (fL) 72 - 74.2 75 75 75.7 74.7 74.9 75.5
MCH (pg) 23.9 - 22.6 23 23.1 23 23 23.1 23.3
MCHC (G/L) 332 - 304 307 308 304 307 308 309
WBC (G/L) 9.3 - 15.4 11.4 11.5 11.9 6.7 8.2 9.8
L-Neu (%) 62.7 - 88.3 93 84.3 80.8 64.7 69.1 71.2
Eo (%) 6.1 - 0.1 0.1 0 0.8 0.2 0.6 2.6
Basophil (%) 1 - 0.4 0.1 0.1 0.8 0.8 0.6 0.6
Mo (%) 6.6 - 5.5 1 6.4 7 7.7 7.3 7.3
Ly (%) 21.2 - 5.8 5.8 9.2 10.6 26.6 22.4 18.3
CRP (mg/L) 2.5 - 40.7 - 43.8 - - 6.1 -
INR - - 1.24 - - 1.17 - 1.1 -
Note.— Basophil = basophil leucocyte, CRP = C-reactive protein, Eo = eosinophil leucocyte, Hgb = haemoglobin, Ht = hematocrit, 
INR = international normalized ratio, Ly = lymphocytes, L-Neu = neutrophil leucocyte, MCH = mean cell haemoglobin content, 
MCHC = mean cell haemoglobin concentration, MCV = mean cell volume, Mo = monocytes, MPV = mean platelet volume, Plt = 
platelet, WBC = white blood cell
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suddenly within 30 minutes of receiving the dose. No data 
on the platelet count of this patient was reported. In our 
case the symptoms started 40 minutes after receiving the 
intravenous contrast material.
Authors of papers from the nineteen eighties reported 
acute thrombocytopenia as a complication of iodinated 
contrast medium (2-5). Severe thrombocytopenia 
and recurrent thrombocytopenia are considered rare 
complications of ICM (1, 8). In our case, the lowest platelet 
count was 2 x 109 L-1 at 20 hours after the administration 
of the contrast medium. No such low platelet count has 
ever been reported before. Most of the studies reported 
platelet counts between 4 and 30 G/L in ICM induced 
thrombocytopenia. 
The mechanism of ICM induced thrombocytopenia remains 
unclear. Most commonly, an immunoallergic mechanism 
is postulated. In vitro studies of the effects of iodinated 
contrast media on platelets have yielded conflicting results. 
Schulze et al. (9) have shown that fibrinogen consumption 
and platelet aggregation with resultant thrombocytopenia 
can be induced in whole blood that is preincubated with 
high concentrations of iodinated contrast media and then 
exposed to platelet-rich plasma. Chang et al. (4) could 
not detect intravenous contrast materia (Renografin-76) 
dependent platelet aggregating factor, and concluded that 
ICM-induced thrombocytopenia was not caused by in vivo 
aggregation of platelets. 
In our case, the in vitro test did not prove the decrease 
of platelet count when intravenous contrast material was 
added to the blood sample of the patient. It should be 
mentioned that the test was performed, as it usually is in 
other reported cases, at the time when the platelet count 
of the patient returned to the normal range. However, the 
experiment confirmed that the ICM has no direct toxicity on 
the platelets of the patient.
We also postulate an immunoallergic mechanism, 
although all the immunological tests were negative. The 
history, the hematological data and the follow up did not 
prove coincidence with immune thrombocytopenia. Based 
on the patient’s history of a malignant disease-urinary 
bladder carcinoma-the possibility of a paraneoplastic 
phenomenon was taken into consideration. However, there 
was no sign of recurrence of the tumor at the time of 
investigation nor during the 14 months follow-up. 
The transient elevation of CRP on days 2 and 3 indicates 
an acute inflammatory reaction most probably in connection 
with the rapid drop in platelet count. No sign of an 
intercurrent viral infection or other infection was detected. 
Since the CRP value was perfectly normal on day 6, it also 
indicates an acute phase reaction.
Since the patient was treated for hypertension with 
different drugs, theoretically, an interaction between ICM 
and a drug can be supposed. However, there is no evidence 
supporting this possibility in this case or in the literature. 
As suggested in the literature, we also administered 
corticosteroids intravenously and administered a platelet 
suspension to prevent fatal bleeding complications. The 
time needed for recovery of platelet counts to normal levels 
was several days, as reported by others (4, 8). The effect of 
intravenous human globulin or plasmapheresis has not been 
proven in similar cases (10).
Even the most modern non-ionic low osmolarity 
intravenous radiographic contrast media can induce acute 
severe thrombocytopenia by an idiosyncratic mechanism in 
hypersensitive patients. The mechanism is still unknown. 
Mostly, an immunoallergic mechanism is supposed. No such 
low platelet count, as in our case of a 72 year old man, has 
ever been reported before. 
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